Announcing a new article publication for Cardiovascular Innovations and Applications journal. Liver fibrosis scores (LFSs) are novel tools for predicting cardiovascular events in patients with ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Aldafermin 3 mg and 1 mg reduced Enhance Liver Fibrosis ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The diagnostic performance of fibrosis-4 index and NAFLD ...

Hypertension in men and an increasing number of cardiometabolic criteria were associated with higher risk for advanced fibrosis and at-risk MASH.

Non-invasive biomarkers and scoring systems demonstrated effectiveness in differentiating chronic liver disease (CLD) from cirrhosis; non-invasive fibrosis scores such as the Lok index, King's score, ...

Chronic liver disease, a growing threat to global health, often progresses silently in its early stages. Detecting its precursor, steatotic liver disease (SLD), and advanced liver fibrosis before ...

Simple FNI labs pinpoint high‑mortality MASLD fibrosis in type 2 diabetes, challenging FIB‑4 and sharpening MASH liver ...

Pemvidutide improves fibrosis markers, liver fat, lipids, weight, and blood pressure in patients with MASH at 1 year, phase ...

The use of Agile scores based on vibration-controlled transient elastography (VCTE) accurately predicted liver-related events in patients with metabolic dysfunction-associated steatotic liver disease ...

Lung CT Biomarkers Linked to ILD Prognosis. E-LUNG CT biomarkers were linked to mortality and future lung function decline in ...